Learn more

PLIVA D D

Overview
  • Total Patents
    157
About

PLIVA D D has a total of 157 patent applications. Its first patent ever was published in 1993. It filed its patents most often in Croatia, Argentina and China. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are PLIVA ISTRAZIVACKI INST D D O, CARUSO MICHELE and CT NAC INVESTIGACIONES ONCOLOGICAS CNIO.

Patent filings per year

Chart showing PLIVA D Ds patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Mesic Milan 28
#2 Mercep Mladen 22
#3 Dumic Miljenko 21
#4 Ala Paul J 17
#5 Magee Andrew S 17
#6 Moe Scott T 17
#7 Danilovski Aleksandar 17
#8 Filic Darko 17
#9 Perola Emanuele 16
#10 Navia Manuel A 15

Latest patents

Publication Filing date Title
HRP20030954A2 USE OF 1-AZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20020603A2 New process for the preparation of modification i n-(1-methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridinesulfonamide
EA007612B1 Structure-based drug design methods for identifying d-ala-d-ala ligase inhibitors as antibacterial drugs
IL159538D0 8/17 heterocyclic compounds and uses thereof as d-alanyl-d-alanine ligase inhibitors
HRP20020453A2 1,3-diaza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediate for preparation thereof
HRP20020452A2 1,2-diaza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediates for preparation thereof
HRP20020451A2 1-tia-3-aza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediates for preparation thereof
HRP20020441A2 1-oxa-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediate for preparation thereof
HRP20020231A2 ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
HRP20020124A2 Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping
HRP20010792A2 Acarbose purification process
US6855707B2 Method for the treatment of lipid and glucose metabolism disorders
HRP20010545A2 Preparation of 5-aminosalicylic acid by electrochemical reduction
HRP20010301A2 New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
HRP20010146A2 9a-N-(N'-(PHENYLSULFONYL)CARBAMOYL) DERIVATIVES OF 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMYCIN A AND OF 5-O-DESOSAMINYL-9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHRONOLIDE A
HRP20010018A2 Novel anti-inflammatory compounds
HRP20000765A2 Compositions of n-(1-methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides with increased release
HRP20000612A2 Hydroxycoumarin derivatives condensation products with aromatic and aliphatic dialdehydes, the preparation and antiviral effect thereof
HRP20000162A2 Amorphous torasemide modification
HRP990192A2 4'-DEMICAROZYL-8a-AZA-8a-HOMOTHILOSINE DERIVATIVES